Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous, as well as heat treatment, quenching, eutectic salt. Kronox Lab Sciences Limited was incorporated in 2008 and is based in Vadodara, India.
| Current Price | ₹197.14 |
|---|---|
| Market Cap | ₹776 Cr |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Industrial Process Chemicals |
| P/E Ratio | 26.7 |
| Return on Equity | 26.82% |
| 52-Week Range | ₹96.00 – ₹227.74 |
| Beta (1Y) | 0.57 |
| Dividend Yield | 0.25% |
| Revenue | ₹28 Cr |
|---|---|
| Net Profit | ₹7 Cr |
| EPS (Basic) | ₹2.00 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Manufacturing of High Purity Specialty Fine Chemical-100%
KRONOX LAB SCIENCES LIMITED is trading at ₹197.14, with a market capitalisation of ₹776 Cr.
KRONOX LAB SCIENCES LIMITED operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Industrial Process Chemicals).
KRONOX LAB SCIENCES LIMITED has a P/E of 26.7 and a return on equity of 26.82%.
In Q1 FY27, KRONOX LAB SCIENCES LIMITED reported revenue of ₹28 Cr and net profit of ₹7 Cr, with basic EPS of ₹2 (standalone, parsed from the company's exchange filing).